Zeroing in on a cure

By Marilee Griffin

The UF Health Cancer Center has been named one of 12 initial clinical trial sites for Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer. Starting in the spring of 2017, participants will enroll at a site and undergo advanced molecular profiling to determine their tumor’s unique molecular features, which will help match them to the substudy that best matches their needs. Patients will be monitored closely and follow-up analyses will provide important clues to help researchers understand the effectiveness of each treatment in real time. Through Precision Promise, an initiative of the national nonprofit organization Pancreatic Cancer Action Network, all data from the 12 sites will be analyzed together so findings can be disseminated in a timely manner.